Found 5 matching trials
A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer
PHASE2This study will evaluate the effectiveness and safety of HRS-4642 in combin...
Location
Jiangsu Province Hospital
HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation
PHASE2This study is a Phase II clinical trial that plans to enroll 40 patients wi...
Location
First Affiliated Hospital of Zhejiang University Schlool of Medicine
A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
PHASE1The study is being conducted to evaluate the safety, tolerability, and effi...
Status
Active Not Recruiting
Location
Shanghai East Hospital
HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors
PHASE1This study is a randomized, open-label, multicenter Phase II clinical trial...
Location
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer
PHASE3This study investigates the first-line treatment of advanced pancreatic can...
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine